Aisha I Abdullah - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Aisha I Abdullah's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Aisha I Abdullah

Aisha I Abdullah

Verified

Writer, Freelance

Pensacola

Final Covers

Medicine ScienceHealth

Doesn’t Cover

Sport.

Journalist Type

-

Seniority Positions

-

Medium Formats

-

Content

Total articles 324

  • LETI-101 lowers mutant HTT protein in preclinical models

    By Marisa Wexler Verified, Tanita Allen, Patricia Inacio, Aisha I Abdullah| Huntington's Disease News Verified LETI-101, an experimental gene-editing therapy for Huntington’s disease, showed promising proof-of-concept effects in mouse and cell models by reducing levels of the disease-causing mutant huntingtin (HTT) protein, while preserving HTT’s healthy version. In nonhuman primates, the therapy showed good safety and distribution across brain regions profoundly impacted by Huntington’s.

    By Marisa Wexler Verified, Tanita Allen, Patricia Inacio, Aisha I Abdullah · Huntington's Disease News

    Mar. 04, 2025

  • Digestive issues common in Rett patients, long-term study finds

    By Patricia Inacio, Marisa Wexler Verified, Aisha I Abdullah| rettsyndromenews.com@ Digestive issues and growth deficits are common and persistent symptoms among classical Rett syndrome patients, according to a long-term study. No correlation was found between the type of mutation in the MECP2 gene, the chief cause of the disease, and the severity of digestive symptoms, which “emphasizes the need for close gastrointestinal and nutritional follow up, regardless of the patient’s specific genetic mutation,” the researchers wrote.

    By Patricia Inacio, Marisa Wexler Verified, Aisha I Abdullah · rettsyndromenews.com

    Sep. 04, 2024

  • LETI-101 lowers mutant HTT protein in preclinical models

    By Marisa Wexler Verified, Tanita Allen, Patricia Inacio, Aisha I Abdullah| Huntington's Disease News Verified LETI-101, an experimental gene-editing therapy for Huntington’s disease, showed promising proof-of-concept effects in mouse and cell models by reducing levels of the disease-causing mutant huntingtin (HTT) protein, while preserving HTT’s healthy version. In nonhuman primates, the therapy showed good safety and distribution across brain regions profoundly impacted by Huntington’s.

    By Marisa Wexler Verified, Tanita Allen, Patricia Inacio, Aisha I Abdullah · Huntington's Disease News

    Mar. 04, 2025

As seen in

Company Info

Freelance

Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.

De Pere, Wisconsin, United States